Moreover, knockout of endogenous mouse tau alleviates Aβ-induced memory deficits [47], suggesting that targeting tau may be a worthwhile AD therapeutic strategy, although another report suggests the opposite [70]. The gene discussed is MAPT; the disease is Alzheimer disease.